LNKCHEMSOLUTIONS

Address

4701 INNOVATION DRIVE
LINCOLN, NE, -

Information

DUNS: 131068186
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Development of Ultrafine Particles for Intranasal Delivery of Antipsychotics

    Amount: $296,413.00

    DESCRIPTION: The goal of the proposed project is to develop a biocompatible ultrafine particle-based vector system for the intranasal delivery of clozapine for the pharmacological therapy of treatment ...

    STTRPhase I2012Department of Health and Human Services
  2. Nanoparticles and Nanocapsules for Glioma Targeting

    Amount: $2,000,001.00

    DESCRIPTION (provided by applicant): Malignant gliomas represent a heterogeneous family of tumors that are poorly responsive to current treatments. A major obstacle to the effective management of thes ...

    SBIRPhase II2011Department of Health and Human Services
  3. Improved Formulations to Enhance Bio-availability for Antisense Therapeutics

    Amount: $70,000.00

    In general, many biological and chemical agents affect the lungs directly or indirectly, even if the respiratory system is not the primary target organ of a military or terrorist attack. Both in the c ...

    SBIRPhase I2010Office for Chemical and Biological Defense Department of Defense
  4. Development of New Hemostatic Dressings

    Amount: $399,994.00

    DESCRIPTION (provided by applicant): A multidisciplinary team of researchers seeks to develop novel and economically feasible implantable hemostatic dressings for severe (e.g. arterial) bleeding. Key ...

    SBIRPhase I2009Department of Health and Human Services
  5. Nanoparticles and Nanocapsules for Glioma Targeting

    Amount: $400,001.00

    DESCRIPTION (provided by applicant): LNK Chemsolutions LLC collaborates with researchers from the University of Chicago to develop nanocapsule technology for enhanced delivery to gliomas. Preliminary ...

    SBIRPhase I2008Department of Health and Human Services
  6. Nanoengineered Encapsulation of Enzyme Chiral Catalysts and Other Proteins in Their Native State

    Amount: $750,000.00

    The commercial opportunities for products based on delicate biomolecules, such as enzymes and therapeutic proteins, are growing at a strong pace. However, many proteins of great commercial value, inc ...

    SBIRPhase II2006Department of Energy
  7. SBIR Phase I: Catalytic Traps for Capture of Gas-Phase Toxic Linear Molecules

    Amount: $100,000.00

    This Small Business Innovation Research (SBIR) Phase I project will explore the use of a material comprising a fibrous substrate and an inorganic adsorbent/catalytic coating for removal of toxic small ...

    SBIRPhase I2006National Science Foundation
  8. STTR Phase I: Nanoengineered Encapsulation of Therapeutics

    Amount: $100,000.00

    This Small Business Technology Transfer (STTR) Phase I project is a feasibility study for the design of true core-shell type nonocapsules for drug delivery. The research will focus on strategies aime ...

    STTRPhase I2006National Science Foundation
  9. Micro/Nano-Encapsulation of Partial Oxidation Biocatalysts

    Amount: $99,999.00

    78011S Many industrial liquid-phase catalytic processes that require the use of some kind of active species (e.g. sensors, biosensors, chelating agents, and chemical traps) cannot be ¿heterogeneized ...

    SBIRPhase I2005Department of Energy
  10. Submicron Particles and Fibers for Toxicological Studies

    Amount: $376,119.00

    DESCRIPTION (provided by applicant): This Phase I SBIR program is aimed at initiating a business venture dedicated to the manufacturing of nanoparticulates for toxicology research. The rate of nanotec ...

    SBIRPhase I2005Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government